Cargando…
How to reduce cisatracurium consumption in ARDS patients: the TOF-ARDS study
BACKGROUND: Neuromuscular blocking agents (NMBAs) have been shown to improve the outcome of the most severely hypoxemic, acute respiratory distress syndrome (ARDS) patients. However, the recommended dosage as well as the necessity of monitoring the neuromuscular block is unknown. We aimed to evaluat...
Autores principales: | Hraiech, Sami, Forel, Jean-Marie, Guervilly, Christophe, Rambaud, Romain, Lehingue, Samuel, Adda, Mélanie, Sylla, Pierre, Valera, Sabine, Carvelli, Julien, Gainnier, Marc, Papazian, Laurent, Bourenne, Jérémy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5540745/ https://www.ncbi.nlm.nih.gov/pubmed/28770545 http://dx.doi.org/10.1186/s13613-017-0305-2 |
Ejemplares similares
-
Response to Prone Position in COVID-19 and Non-COVID-19 Patients with Severe ARDS Supported by vvECMO
por: Textoris, Laura, et al.
Publicado: (2023) -
Herpes simplex virus and Cytomegalovirus reactivation among severe ARDS patients under veno-venous ECMO
por: Hraiech, Sami, et al.
Publicado: (2019) -
Venovenous extracorporeal membrane oxygenation devices-related colonisations and infections
por: Thomas, Guillemette, et al.
Publicado: (2017) -
Transpulmonary pressures in obese and non-obese COVID-19 ARDS
por: Mezidi, Mehdi, et al.
Publicado: (2020) -
Impact of obesity on survival in COVID-19 ARDS patients receiving ECMO: results from an ambispective observational cohort
por: Daviet, Florence, et al.
Publicado: (2021)